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In the last decade, cognitive psychopathology has shed
light on how abnormal changes in cognitive functions,
which are closely related to emotional and relational pro-
cesses, may explain development, maintenance, and recur-
rence of psychiatric disorders and how dysfunction of cer-
tain brain areas determine specific cognitive phenotypes
characterizing psychiatric disorders (1). Episodic memory
impairment accounting for a severe damage of a sense of
self and a lack of autonoetic consciousness in schizophre-
nia was first reported in a previous study (2). Neuropsy-
chological investigations have also demonstrated that pa-
tients with Bipolar Disorder (BD) present persistent cog-
nitive impairment even during the euthymic phase (3).
Given high rates of neurocognitive impairment in BD
and their relevance for functional outcome, these deficits
should be considered as primary targets for treatment.
In light of this assumption, the aim of cognitive psy-
chopathology is to suggest a relationship between cogni-
tive dysfunction and clinical symptoms and to indicate
treatment directions. In the current study, 20 patients (M:F
= 12:8, mean age 39, mean education of 11 years) were diag-
nosed with BD type I, according to DSM-V criteria (4) in a
current euthymic phase. They were assessed by brief neu-
rocognitive exam (BNE) (5) (overall cognitive screening),
digit span (short-term verbal memory) (split-half reliabil-
ity = 0.90) (6), Corsi Span (short-term visuospatial mem-
ory) (test-retest reliability = 0.38), Pairs Associates Leaning
(long-term verbal memory) (test-retest reliability = 0.59),
Memory of Prose (long-term verbal memory) (test-retest
reliability = 0.69), Corsi Learning Suvra-span (long-term vi-
suospatial memory) (test-retest reliability = 0.80), Visual
Search Test (selective attention) (test-retest reliability =
0.53) (7), frontal assessment battery (FAB) Go-No-Go sub-
test (inhibitory control) (inter-rater reliability =.96; test-
retest reliability = 0.85) (8), Tower of London Drexel version
(ToLDX) (planning abilities) (test-retest reliability = 0.80)
(9), Stroop Test (interference control) (test-retest reliabil-
ity =0.85) (10), Brixton test (detecting rules in sequence of
stimuli) (inter-rater reliability =0.96) (11), and picture in-
terpretation test (PIT) (logical inference) (Cohen’s kappa
statistic PIT and Verbal Fluency = 0.76, P < 0.001) (12). Writ-
ten informed consent was obtained by the patients. On
BNE, BD patients presented difficulties in divided atten-
tion, cognitive flexibility, and visual-perceptual abilities.
According to the literature, BD patients poorly sustain cog-
nitive tasks overload that is associated to altered impulsive
control (13). Non-parametric Wilcoxon tests to compare
patients’ performances on memory, attentional/executive
measures showed that patients performed worse on plan-
ning abilities than interference control and ability to de-
tect rule in sequences of stimuli (P < 0.05). These results
confirm that all the aspects of executive function, consis-
tent with failures in goal selection, evaluation and exe-
cution, are significantly affected in patients with BD (14).
More interestingly, a Spearman’s Rank correlation showed
a negative association between FAB subtest Go-No-Go and
PIT (rho = -0.583, P < 0.01). In the euthymic phase, pa-
tients experience an inhibitory control that is probably
more efficient than in affective episodes: they may present
a decrease of logical inference because they are more en-
gaged in self-monitoring. Thus, clinical amelioration of
patients has a cost pertaining executive efficiency. Accord-
ing to recent studies (15), we suggest that patients with BD
should undergo specific cognitive remediation (CR) pro-
grams to better plan and organize activities, break down
complex tasks to simpler ones, learn how to coach them-
selves more adaptively in presence of disturbed thoughts,
and conform social behaviour from correct inference, in
order to counteract executive dysfunction representing a
persistent core deficit of the euthymic phase. The CR pro-
grams usually consist of 1 or 2 individual session(s) of 1-
hour weekly held for 4/6 months (16, 17), in which partic-
ipants completed computerized adaptive cognitive tasks
frequently used in severe mental diseases (18). Participants
may be taught cognitive strategies about memory, concen-
tration and planning and therapists should facilitate re-
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flection around how these strategies can be applied to ev-
eryday goals (e.g. domestic life or job when possible) (19).
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